Influence of Lipopolysaccharide-Interacting Peptides Fusion with Endolysin LysECD7 and Fatty Acid Derivatization on the Efficacy against Acinetobacter baumannii Infection In Vitro and In Vivo
Open Access
Abstract
Acinetobacter baumannii has developed multiple drug resistances, posing a significant threat to antibiotic efficacy. LysECD7, an endolysin derived from phages, could be a promising therapeutic agent against multi-drug resistance A. baumannii. In this study, in order to further enhance the antibacterial efficiency of the engineered LysECD7, a few lipopolysaccharide-interacting peptides (Li5, MSI594 and Li5-MSI) were genetically fused with LysECD7. Based on in vitro antibacterial activity, the fusion protein Lys-Li5-MSI was selected for further modifications aimed at extending its half-life. A cysteine residue was introduced into Lys-Li5-MSI through mutation (Lys-Li5-MSIV12C), followed by conjugation with a C16 fatty acid chain via a protonation substitution reaction(V12C-C16). The pharmacokinetic profile of V12C-C16 exhibited a more favorable characteristic in comparison to Lys-Li5-MSI, thereby resulting in enhanced therapeutic efficacy against lethal A. baumannii infection in mice. The study provides valuable insights for the development of novel endolysin therapeutics and proposes an alternative therapeutic strategy for combating A. baumannii infections.Keywords
This publication has 27 references indexed in Scilit:
- Molecular mechanisms of antibiotic resistance revisitedNature Reviews Microbiology, 2022
- Derivatization with fatty acids in peptide and protein drug discoveryNature Reviews Drug Discovery, 2022
- Determination of Bactericidal Activity Spectrum of Recombinant Endolysins of ECD7, Am24, Ap22, Si3, and St11 BacteriophagesBulletin of Experimental Biology and Medicine, 2021
- Advanced engineering of third-generation lysins and formulation strategies for clinical applicationsCritical Reviews in Microbiology, 2020
- A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearanceInternational Journal of Antimicrobial Agents, 2011
- Structure, Interactions, and Antibacterial Activities of MSI-594 Derived Mutant Peptide MSI-594F5A in Lipopolysaccharide Micelles: Role of the Helical Hairpin Conformation in Outer-Membrane PermeabilizationJournal of the American Chemical Society, 2010
- Lipopolysaccaride-binding peptides obtained by phage display methodJournal of Microbiological Methods, 2010
- Structure, membrane orientation, mechanism, and function of pexiganan — A highly potent antimicrobial peptide designed from magaininBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144Biochemical and Biophysical Research Communications, 2009
- Nosocomial Outbreak of Infection With Pan–Drug-ResistantAcinetobacter baumanniiin a Tertiary Care University HospitalInfection Control & Hospital Epidemiology, 2009